LabCorp launches novel coronavirus test

By staff writers

March 10, 2020 -- LabCorp has released a nucleic acid amplification (NAA) test for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.

LabCorp developed the test internally, and it is making it available according to guidance posted by the U.S. Food and Drug Administration (FDA) on February 29. The qualitative assay uses polymerase chain reaction (PCR) technology and has been validated for use with respiratory samples, the company said. Results are available in three to four days.

The company is also able to perform the U.S. Centers for Disease Control and Prevention's 2019-nCoV real-time reverse transcription PCR diagnostic panel, it said.

LabCorp posts strong financial results for Q4
Life sciences company LabCorp posted strong financial gains for its fourth quarter but mixed results for the entire 2019 fiscal year.
LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine precision assay...
Qiagen, LabCorp expand partnership
LabCorp plans to tap into Qiagen's Human Gene Mutation Database for rare and inherited conditions across its network of laboratories per an expansion...
LabCorp joins forces with Ind. nonprofit
LabCorp has acquired the diagnostic clinical laboratory assets of the Indiana-based nonprofit South Bend Medical Foundation (SBMF) and will be providing...
LabCorp in the midst of CEO shuffle
LabCorp is undergoing top-level executive changes in its business segments, with the appointment of John Ratliff as CEO of LabCorp Diagnostics and Dr. Paul...

Copyright © 2020

Last Updated np 3/10/2020 12:09:48 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current